INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.142, sa.1, ss.72-79, 2010 (SCI-Expanded)
Background: Predictive value of apolipoprotein (apo) A-I for incident hypertension, metabolic syndrome (MetS), type 2 diabetes (DM) and coronary heart disease (CHD) needs further exploration.